AstraZeneca PLC announced board and board committee appointments: With effect from 1 October 2018, Joseph G. Peter (Joe) is appointed as a Non -Executive Director and a member of the Audit Committee; With effect from 1 January 2019, Graham Chipchase will become senior independent Non-Executive Director of the Company; with effect from 1 December 2018, Philip Broadley will become a member of the Remuneration Committee and with effect from 1 March 2019, he will become a member of the Nomination and Governance Committee. As previously announced, Rudy Markham intends to retire from the Board at the conclusion of the Company's 2019 Annual General Meeting. Joseph G. Peter (Joe) recently retired as the Chief Financial Officer for Nissan Motor Company, a position he held for nine years. Mr. Chipchase has served as a Director for six years. He has chaired the Remuneration Committee and been a member of the Nomination and Governance Committee since April 2015, having previously served as a member of the Audit Committee from 2012 to 2014. Mr. Broadley became a Director and a member of the Audit Committee in April 2017.